the Relationship of the Use of Eye Masks and Outcomes of Patients With Sepsis in Intensive Care Unit

Sponsor
Shanghai 10th People's Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02304224
Collaborator
(none)
100
1
2
14
7.1

Study Details

Study Description

Brief Summary

The aim of the study is to investigate the relationship of nocturnal use of eye masks and immune function, cerebral function and outcomes of patients with sepsis. Thus more efficient and comprehensive treatment could be provided for patients in the duration of admission in intensive care unit.

Condition or Disease Intervention/Treatment Phase
  • Other: eye masks
N/A

Detailed Description

  1. Treatment for patients There are no significant difference in standardized treatment received by patients enrolled, as well as the light equipment bedside and the food supply time. Patients are randomly divided into Eye Masks Group and Control Group by computer tools. Patients in Eye Masks Group are applied with eye masks from 22: 00 to 6: 00 each night during the admission. Blood sample was collected from each patient immediately after enrollment (D0), 6:30 of Day 1 (D1), Day 1 (D2), Day 3 (D3), Day 4 (D4) after admission. Urine of 6:00-21:00 and 21:00-6:00 is also stored from D0 to D4.

  2. Clinical data collection Data such as patient's age, gender, contact information, time from onset to admission, existence of septic shock, pathogen species, the site of infection, the existence of organ dysfunction, APACHE II score (Acute Physiology And Chronic Health Evaluation Scoring System) , SOFA (Sequential Organ Failure Assessment)score, the use of mechanical ventilation, vasoactive drugs, corticosteroids, sedative and analgesic medication, history of eye diseases and neurological diseases is collected from each patient who is included in the study. Follow-up data for daily daytime sleep time, existence of delirium, CPC score and GCS score on Day 7 and Day 28, length of stay and survival of 28 days after admission is also collected.

  3. Sample collection and processing The blood samples collected in citrate anticoagulation tubes and the urine samples collected in specialized graduated cylinders are stored at room temperature. Staining and fixation were performed within 24 h after blood collection. The expression of Monocyte Human Leukocyte Antigen-DR is detected using flow cytometer. The concentration of 6-sulfatoxymelatonin in urine is detected by ELISA kit.

  4. Cerebral Performance Category (CPC) CPC is a 5-category scale for measuring neurological status 2 weeks after cardiac arrest and CPC score 6 months after cardiac arrest. The 5 categories are: CPC 1, conscious and alert with good cerebral performance; CPC 2, conscious and alert with moderate cerebral performance; CPC 3, conscious with severe cerebral disability; CPC 4, comatose or in persistent vegetative state; and CPC 5, brain dead, circulation preserved.

  5. Glasgow Coma Scale (GCS) The GCS was developed as a standardized method for healthcare practitioners to evaluate degree of altered consciousness in patients who had sustained head injuries. The GCS is comprised of three categories: eye opening, verbal response, and motor response. The score from each category is summed, to provide a total GCS score (range 3-15).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
the Relationship of the Use of Eye Masks and Outcomes of Patients With Sepsis in Intensive Care Unit
Study Start Date :
Dec 1, 2014
Anticipated Primary Completion Date :
Dec 1, 2015
Anticipated Study Completion Date :
Feb 1, 2016

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

the patients with sepsis admitted in the intensive care unit aren't applied with eye masks at night

Experimental: Eye masks

the patients with sepsis in the intensive care unit are applied with eye masks at night in the duration of admission

Other: eye masks
eye masks from 21:00 to 6:00 each night during admission

Outcome Measures

Primary Outcome Measures

  1. survival of participants [up to 28 days after hospitalization]

Secondary Outcome Measures

  1. Cerebral Performance Category(CPC) of Participants [up to 7 days after hospitalization]

  2. Cerebral Performance Category(CPC) of Participants [up to 28 days after hospitalization]

  3. Glasgow Coma Scale (GCS) of Participants [up to 7 days after hospitalization]

  4. Glasgow Coma Scale (GCS) of Participants [up to 28 days after hospitalization]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Transferred into ICU before 21:00 the same day;

  2. Consistent with the diagnosis of sepsis;

  3. Written informed consent was obtained from patients or their family members.

Exclusion Criteria:
  1. Age < 18 years;

  2. With sleep disorders; mental illness; cancer; autoimmune diseases; dysfunction of liver or kidney;

  3. History of using of immune-related drugs; melatonin receptor agonist or antagonist; sleep-aid or mental- related drugs;

  4. History of accepting radiotherapy or chemotherapy;

  5. Doing shift work before admission.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shanghai Tenth Hospital Shanghai China 200000

Sponsors and Collaborators

  • Shanghai 10th People's Hospital

Investigators

  • Study Chair: Yuanzhuo Chen, M.D., Shanghai 10th People's Hospital
  • Principal Investigator: Wenjie Li, M.D., Shanghai 10th People's Hospital
  • Principal Investigator: Huiqi Wang, M.D., Shanghai 10th People's Hospital
  • Study Director: Chengjin Gao, M.D., Shanghai 10th People's Hospital
  • Study Director: Hu Peng, M.D., Shanghai 10th People's Hospital
  • Principal Investigator: Yugang Zhuang, M.D., Shanghai 10th People's Hospital
  • Study Director: Xiangyu Zhang, M.D., Shanghai 10th People's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chen Yuanzhuo, M.D., Shanghai 10th People's Hospital
ClinicalTrials.gov Identifier:
NCT02304224
Other Study ID Numbers:
  • 040114002
First Posted:
Dec 1, 2014
Last Update Posted:
Dec 1, 2014
Last Verified:
Nov 1, 2014
Keywords provided by Chen Yuanzhuo, M.D., Shanghai 10th People's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 1, 2014